What is Aurinia Pharmaceuticals's net investment in lease?

Aurinia Pharmaceuticals (AUPH) reported net investment in lease of $1.66M in Q1 2026.

How has Aurinia Pharmaceuticals's net investment in lease changed year-over-year?

Aurinia Pharmaceuticals's net investment in lease decreased by 58.0% year-over-year, from $3.95M to $1.66M.

What is the long-term trend for Aurinia Pharmaceuticals's net investment in lease?

Over 5 years (2020 to 2025), Aurinia Pharmaceuticals's net investment in lease has grown at a -8.1% compound annual growth rate (CAGR), from $5.49M to $3.6M.

Aurinia Pharmaceuticals AUPH Net Investment in Lease

Net Investment in Lease at other companies

Rogers CorporationROG

——

Agios PharmaceuticalsAGIO

——

Kiniksa Pharmaceuticals International, plcKNSA

——

Alumis Inc.ALMS

——

Apogee Therapeutics, Inc.APGE

——

LQD

Liquidia CorporationLQDA

——

Other financials

Income statement

See full

Revenue$77.7M+24.4%

Gross profit$71.2M+32.1%

Operating income$41.4M+89.6%

Net income$34.4M+47.2%

EPS (diluted)$0.25+56.3%

Balance sheet

See full

Cash & equivalents$41.0M-38.3%

Total debt$85.2M-7.9%

Total equity$567.6M+62.1%

Total assets$724.0M+43.4%

Cash flow

See full

Operating cash flow$32.6M+2,405%

Valuation

See full

Market cap$2.3B+78.5%

Enterprise value$2.34B+78.3%

P/E7.7×-24.6×

P/S7.7×+2.5×

Profitability

See full

Gross margin89.7%+1.5pp

Operating margin41.7%+29.4pp

Net margin100%+83.9pp

Returns & leverage

See full

Return on equity65%+53.8pp

Debt / equity0.2×-0.1×

Current ratio5.5×-0.4×

Where this comes from

Reported directly by Aurinia Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Aurinia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aurinia Pharmaceuticals's net investment in lease.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Aurinia Pharmaceuticals's net investment in lease?: Aurinia Pharmaceuticals (AUPH) reported net investment in lease of $1.66M in Q1 2026.
How has Aurinia Pharmaceuticals's net investment in lease changed year-over-year?: Aurinia Pharmaceuticals's net investment in lease decreased by 58.0% year-over-year, from $3.95M to $1.66M.
What is the long-term trend for Aurinia Pharmaceuticals's net investment in lease?: Over 5 years (2020 to 2025), Aurinia Pharmaceuticals's net investment in lease has grown at a -8.1% compound annual growth rate (CAGR), from $5.49M to $3.6M.